跳至主要内容
临床试验/CTRI/2019/11/022116
CTRI/2019/11/022116尚未招募未知

Evaluation of octreotide as a potential agent for therapy in steroid resistant SSTR(Somatostatin Receptor) positive Graves orbitopathy

Research Section AIIMS New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a) patients with Graves orbitopathy with failed first line of intravenous steroid therapy, before starting second line b) age more than 18 years c) Clinical activity score more than 3 d) with contraindication for other immunosuppressive therapy

排除标准

  • 1) Pregnant and lactating women. 2) Patient on another immunosuppressive therapy 3) patients urgently needing surgical decompression 4) Impending Dysthroid optic neuropathy (DON) 5) Patients in whom urgent second line therapy is required

研究者

发起方
Research Section AIIMS New Delhi

相似试验